Pulmonary function tests (PFTs) are integral to the diagnosis, management, and monitoring of respiratory diseases. However, interpreting these results can often be complex and challenging. This guide aims to simplify the process and enhance understanding among healthcare professionals.
Primarily, PFTs are composed of spirometry, lung volumes, and diffusing capacity. Spirometry measures the air that can be exhaled or inhaled forcefully and quickly, providing information about airflow obstruction. Lung volumes assess the total amount of air lungs can hold, while diffusing capacity evaluates how well oxygen moves from the lungs to the bloodstream.
The key values in spirometry are Forced Vital Capacity (FVC), Forced Expiratory Volume in one second (FEV1), and their ratio (FEV1/FVC). Normal values are age, sex, and height-dependent. A reduced FEV1/FVC ratio indicates airflow obstruction, commonly seen in conditions like asthma or COPD.
Increased lung volumes suggest air trapping or hyperinflation, often seen in obstructive diseases. Reduced volumes can indicate restrictive lung disease. A decreased diffusing capacity can signify interstitial lung disease or emphysema, while an increased value may be seen in asthma or polycythemia.
Recognizing patterns in PFT results is crucial. Obstructive pattern is characterized by reduced FEV1/FVC ratio with normal or increased lung volumes. A restrictive pattern shows reduced lung volumes with a normal or increased FEV1/FVC ratio. A mixed pattern demonstrates features of both.
Decoding PFT results is a skill that improves with practice. Understanding the components of PFTs and recognizing patterns can help healthcare professionals make accurate diagnoses and guide treatment. Continuous learning and experience are essential in mastering this important aspect of respiratory medicine.
1.
When does a melanoma metastasize? Implications for management
2.
Asandeutertinib Tops Osimertinib for NSCLC With Brain Mets
3.
Mammography with AI support is a secure method for detecting breast cancer.
4.
Compared to previous estimates, a greater number of patients participate in cancer treatment trials.
5.
The biology of cancer as well as potential treatment options are examined by experts.
1.
Case Study: Diagnostic and Therapeutic Challenges in Aplastic Anemia Mimicking Hypoplastic Myelodysplastic Syndrome
2.
HPV and Immunotherapy in Cancer Survivorship: National Cancer Survivors Day Review
3.
Tumor-Associated Stroma Regeneration Models
4.
Colorectal Cancer Incidence Trends: A Growing Concern in 2024 and 2025
5.
Immunotherapy Tolerance in Older Adults With Cancer
1.
International Conference on Innovations in Critical Care for Oncology and Cardiology
2.
International Conference on Oncology, Cardiology and Critical Care Policy
3.
International Conference on Oncology, Cancer Prevention and Public Health
4.
International Conference on Cancer Nursing and Rehabilitation Strategies
5.
International Conference on Best Practices in Oncology, Cardiology and Critical Care
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation